Bottom line
Is SWHFX a good fund? The bottom line
SWHFX is a managed health care sector mutual fund from Schwab.
It charges 0.8% — about $80 a year on every $10,000 invested, cheaper than 61% of health care sector funds we track.
It returned +15.9% over one year, +6.5% a year over five years, +8.1% a year over ten (as of Dec 31, 2025, per its prospectus).
With $642 million in net assets and 80 holdings, its largest position is Eli Lilly & Co (13.9%) and the top 10 make up 49.9% of the portfolio.
The closest lower-cost alternative we found is XLV (0.08%, 76% top-holdings overlap).
What stands out
- 5-year return beat 78% of category peers
Updated Nov 19, 2026
What SWHFX invests in
The fund seeks long-term capital growth.
To pursue its goal, the fund primarily invests in equity securities issued by companies in the health care sector. The health care sector may include, for example, pharmaceutical and biotechnology companies, health care facilities operations, medical product manufacturers and suppliers, medical providers and medical services firms. It is the funds policy that under normal circumstances it will invest at least 80% of its net assets (including, for this purpose, any borrowings for investment purposes) in these securities; typically, the actual percentage will be higher. The fund will notify its shareholders at least 60 days before changing this policy. The fund will concentrate its investments in securities of companies in the health care sector. The fund primarily invests in U.S. companies, but may invest up to 25% of its net assets in the stocks of publicly traded companies located in…
From the fund's prospectus (filed Feb 26, 2026).
SWHFX performance
| 1 yr | 5 yr | 10 yr | |
|---|---|---|---|
| SWHFX | +15.9% | +6.5% | +8.1% |
| Health Care Sector median | +14.5% | +4.2% | +7.9% |
Source: Fund prospectus, as of Dec 31, 2025
What SWHFX costs
On a $10,000 investment, SWHFX's 0.8% expense ratio costs about $80 a year. The prospectus estimates $990 in total costs over 10 years (assuming 5% annual returns). The median health care sector fund charges 0.96%.
SWHFX top 10 holdings
| # | Holding | % of fund |
|---|---|---|
| 1 | Eli Lilly & Co | 13.92% |
| 2 | Johnson & Johnson | 6.94% |
| 3 | AbbVie Inc | 5.81% |
| 4 | Merck & Co Inc | 4.98% |
| 5 | UnitedHealth Group Inc | 4.74% |
| 6 | Gilead Sciences Inc | 3.24% |
| 7 | Novartis AG | 2.92% |
| 8 | Amgen Inc | 2.58% |
| 9 | Bristol-Myers Squibb Co | 2.44% |
| 10 | Medtronic PLC | 2.29% |
Source: SEC Form N-PORT, period ended Jul 31, 2026
The top 10 make up 49.9% of the fund. See all top 25 holdings and asset mix →
Alternatives to SWHFX
| Family | Fund | Expense ratio | Overlap | |
|---|---|---|---|---|
| SPDR (State Street) | XLV State Street(R) Health Care Select… | 0.08% | 76% | Compare |
| Fidelity | FHLC Fidelity MSCI Health Care Index ETF | 0.084% | 76% | Compare |
| Vanguard | VHT Vanguard Health Care Index Fund | 0.09% | 75% | Compare |
| iShares | IXJ iShares Global Healthcare ETF | 0.38% | 76% | Compare |
| J.P. Morgan | JDOC JPMorgan Healthcare Leaders ETF | 0.65% | 57% | Compare |
| T. Rowe Price | PRHSX T. Rowe Price Health Sciences Fund, Inc. | 0.83% | 73% | Compare |